Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Seagen Inc (SGEN)  
$228.74 0.00 (0.00%) as of 4:30 Wed 12/13


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 180,310,000
Market Cap: 41.24(B)
Last Volume: 799,597 Avg Vol: 865,460
52 Week Range: $191.51 - $228.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 39,326 485,736
Total Sell Value $0 $0 $8,245,949 $88,282,436
Total People Sold 0 0 7 8
Total Sell Transactions 0 0 18 71
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 1805
  Page 27 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Siegall Clay B President and CEO   •       •      –    2017-08-17 4 A $0.00 $0 D/D 67,200 703,635     -
   Liu Jean I GC/EVP, Leg Affairs   •       –      –    2017-08-17 4 A $0.00 $0 D/D 17,000 68,400     -
   Himes Vaughn B Chief Technical Officer   •       –      –    2017-08-17 4 A $0.00 $0 D/D 20,000 171,283     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2017-08-17 4 A $0.00 $0 D/D 35,000 122,767     -
   Drachman Jonathan G CMO & EVP, R & D   •       –      –    2017-08-17 4 A $0.00 $0 D/D 27,000 142,204     -
   Cline Darren S EVP, Commercial   •       –      –    2017-08-17 4 A $0.00 $0 D/D 17,000 78,656     -
   Siegall Clay B President and CEO   •       •      –    2017-08-07 4 AS $48.91 $509,300 D/D (10,413) 636,435     -
   Siegall Clay B President and CEO   •       •      –    2017-08-07 4 OE $10.29 $107,150 D/D 10,413 646,848     -
   Cline Darren S EVP, Commercial   •       –      –    2017-08-07 4 S $49.19 $295,110 D/D (6,000) 61,656     -
   Cline Darren S EVP, Commercial   •       –      –    2017-08-07 4 OE $18.46 $110,760 D/D 6,000 67,656     -
   Drachman Jonathan G CMO & EVP, R & D   •       –      –    2017-07-27 4 AS $54.54 $545,361 D/D (10,000) 115,204     -
   Drachman Jonathan G CMO & EVP, R & D   •       –      –    2017-07-27 4 OE $10.29 $102,900 D/D 10,000 125,204     -
   Siegall Clay B President and CEO   •       •      –    2017-07-05 4 AS $51.86 $541,807 D/D (10,423) 636,435     -
   Siegall Clay B President and CEO   •       •      –    2017-07-05 4 OE $10.29 $107,253 D/D 10,423 644,629     -
   Drachman Jonathan G CMO & EVP, R & D   •       –      –    2017-06-22 4 AS $64.00 $640,058 D/D (10,000) 115,204     -
   Drachman Jonathan G CMO & EVP, R & D   •       –      –    2017-06-22 4 OE $10.29 $102,900 D/D 10,000 125,204     -
   Siegall Clay B President and CEO   •       •      –    2017-06-05 4 AS $65.17 $679,698 D/D (10,423) 636,435     -
   Siegall Clay B President and CEO   •       •      –    2017-06-05 4 OE $10.29 $107,253 D/D 10,423 646,195     -
   Himes Vaughn B Chief Technical Officer   •       –      –    2017-05-31 4 AS $62.54 $625,922 D/D (10,000) 151,283     -
   Himes Vaughn B Chief Technical Officer   •       –      –    2017-05-31 4 OE $9.23 $92,300 D/D 10,000 160,683     -
   Baker Brothers Life Sciences Lp Director   –       •       •   2017-05-19 4 A $66.60 $492,840 I/I 7,400 40,898,792     -
   Simonian Nancy A Director   –       •      –    2017-05-19 4 A $0.00 $0 D/D 3,700 18,100     -
   Welch Daniel G Director   –       •      –    2017-05-19 4 A $0.00 $0 D/D 3,700 49,219     -
   Gryska David W Director   –       •      –    2017-05-19 4 A $0.00 $0 D/D 3,700 41,350     -
   Orwin John A Director   –       •      –    2017-05-19 4 A $0.00 $0 D/D 3,700 18,100     -

  1805 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 27 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed